AzTrials
AzTrials

Severe PneumoniaNCT07112976

Lung Response to a Higher PEEP During Severe Pneumonia: a CT Study

An observational study of Severe Pneumonia, run by Istituto Clinico Humanitas at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

At their institution, the investigators routinely assess the individual response of mechanically ventilated patients with acute respiratory failure to higher positive end-expiratory pressure (PEEP) by examining changes in lung aeration through lung computed tomography (CT). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Severe Pneumonia
How many people
47 participants
Where
1 siteItaly
Study dates
1 Oct 2022to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults admitted to the ICU with severe pneumonia, treated with mechanical ventilation

Who may be able to join

  • adult (≥18 years of age) patients
  • admitted to ICU from 1/10/2022 to 31/12/2024
  • with severe pneumonia
  • treated with mechanical ventilation
  • who underwent the two lung CTs at 10 and 15 cmH2O

Who cannot join

  • pneumothorax
  • pneumomediastinum
  • lung CT was obtained with contrast medium to rule out pulmonary embolism

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Humanitas Research Hospital

    Milan

Other trials in Italy

About this study

Official title: Effect of a Higher Positive End-expiratory Pressure (PEEP) on Lung Hyperinflation and Collapse in Patients With Severe Pneumonia: a Computed Tomography Study

At their institution, the investigators routinely assess the individual response of mechanically ventilated patients with acute respiratory failure to higher positive end-expiratory pressure (PEEP) by examining changes in lung aeration through lung computed tomography (CT). They typically obtain two lung CT scans during an end-expiratory hold, one at a PEEP of 10 cmH2O and another at 15 cmH2O. Recruitment and hyperinflation are measured by assessing the decrease in the volume of non-aerated lung regions (with a density greater than -100 HU) and the increase in the volume of hyperinflated lung regions (with a density of less than -900 HU) between the two CT scans. If recruitment exceeds hyperinflation, the response to higher PEEP is considered "positive", and medical doctors are encouraged to treat that patient with a higher PEEP. Conversely, if hyperinflation exceeds recruitment, the response is deemed "negative", and a higher PEEP is discouraged. This assessment is further complemented by a "PEEP test," during which gas exchange (specifically arterial oxygen and carbon dioxide tension) and respiratory system mechanics (including compliance) are evaluated while ventilating with PEEP levels of 10 and 15 cmH2O.

In this retrospective analysis, the investigators will focus on patients with severe pneumonia who underwent the two lung CTs as part of their routine clinical practice. They will retrieve data on primary demographic characteristics, significant comorbidities, causes of pneumonia, severity of acute illness, and treatments delivered. Additionally, they will review the results of the quantitative analysis of the lung CT scans taken at 10 and 15 cmH2O, and the PEEP tests. The primary aim of this study is to determine the proportion of patients with net hyperinflation in response to higher PEEP.

Keywords
Mechanical ventilation, Positive end-expiratory pressure, Hyperinflation, Recruitment, Computed tomography
Medical subject headings
Pneumonia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lung response to a higher PEEP

    The primary study objective is to evaluate the effects of higher PEEP with quantitative analysis of lung CT scans in patients with severe pneumonia. We hypothesize that 50% of these patients will exhibit more hyperinflation than recruitment.

    We measure recruitment and hyperinflation by assessing the change in the volume of non-aerated lung regions (with a density greater than -100 HU) and hyperinflated lung regions (with a density of less than -900 HU) between the two CT scans.

    Measured: The effects of a higher PEEP will be assessed by comparing the CT scans taken at ICU admission, with a PEEP of 10 or 15 cmH2O, within the same subject. Usually, the interval between the two CT scans is a few minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2025
  2. Study start1 Oct 2022
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07112976
Sponsor's protocol ID
Studio retrospettivo n. 28/25
Status last verified
Aug 2025
First submitted
3 Jul 2025
Last updated
13 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Protti A, Santini A, Pennati F, Chiurazzi C, Cressoni M, Ferrari M, Iapichino GE, Carenzo L, Lanza E, Picardo G, Caironi P, Aliverti A, Cecconi M. Lung Response to a Higher Positive End-Expiratory Pressure in Mechanically Ventilated Patients With COVID-19. Chest. 2022 Apr;161(4):979-988. doi: 10.1016/j.chest.2021.10.012. Epub 2021 Oct 16.

    PubMed 34666011

Questions about this trial

What is this clinical trial studying?

An observational study of Severe Pneumonia, run by Istituto Clinico Humanitas at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lung response to a higher PEEP (time frame: The effects of a higher PEEP will be assessed by comparing the CT scans taken at ICU admission, with a PEEP of 10 or 15 cmH2O, within the same subject. Usually, the interval between the two CT scans is a few minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07112976, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in